News Releases

November 12, 2015

RepliCel Executives to Present at 9th World Congress for Hair Research in Miami
Conference brings together hair biologists, dermatologists, cosmetic scientists and leading biotech companies to discuss the advancement of knowledge in hair growth and research VANCOUVER,... Read full article

November 4, 2015

RepliCel Selected as One of This Year’s Top 20 Public Canadian Technology Companies
Canadian Innovation Exchange (CIX) Public Investor Day November 18 at Toronto’s MaRS Discovery District to showcase ‘Canada’s hottest and most innovative public technology companies’... Read full article

October 20, 2015

RepliCel Life Sciences Inc. Announces Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – October 20, 2015 – RepliCel... Read full article

October 20, 2015

First Participants Enrolled in RepliCel’s Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
Testing the use of a cell-based injectable as a regenerative alternative for the global dermal filler market addressing aged and UV-damaged skin  VANCOUVER, BC... Read full article

October 15, 2015

Industry Leader Geoff MacKay Joins RepliCel Life Sciences’ Board of Directors
VANCOUVER, BC – October 15, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company focused on the... Read full article

October 8, 2015

RepliCel Announces October Presentation and Partnering Meeting Schedule
VANCOUVER, BC – October 8, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company focused on the... Read full article

September 23, 2015

RepliCel Presenting at Two Upcoming Investment and Partnering Forums
A Chinese-based investor forum in Toronto and an aesthetics & dermatology conference in Newport Beach showcase RepliCel among industry leaders, high-growth companies and active... Read full article

September 15, 2015

RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study
Clinical trial site located at IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany VANCOUVER, BC – September 15, 2015 – RepliCel Life Sciences Inc.... Read full article

September 1, 2015

RepliCel Life Sciences Cleared to Initiate Clinical Trial of RCS-01 for Dermal Rejuvenation
Patient recruitment will take place at the IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany VANCOUVER, BC – September 1, 2015 – RepliCel Life... Read full article

August 28, 2015

RepliCel Reports Second Quarter 2015 Financial Results
VANCOUVER, BC – August 28, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP), a clinical stage regenerative medicine company focused on the... Read full article